Pimecrolimus 1% cream for pruritus in postmenopausal diabetic women with vulvar lichen simplex chronicus: A prospective non‐controlled case series
Pimecrolimus 1% cream for pruritus in postmenopausal diabetic women with vulvar lichen simplex chronicus: A prospective non‐controlled case series
复制标题
1%吡美莫司乳膏治疗患有外阴慢性单纯性苔藓的绝经后糖尿病女性的瘙痒:前瞻性非对照病例系列
DOI:
10.1080/09546630801955341
复制
发表时间:
2008
期刊:
影响因子:
--
通讯作者:
Sefa Kelekci˙
中科院分区:
文献类型:
--
作者:
Handan Ki˙ymet Kelekci˙;H. Uncu;Bulent Yi˙lmaz;Orcun Ozdemi˙r;N. Sut;Sefa Kelekci˙
Background: Pruritus vulvae may have a variety of causes, such as infections, dermatologic disorders or non‐neoplastic/neoplastic vulvar diseases. Objectives: To investigate the efficacy and side effects of topical pimecrolimus 1% cream for pruritus vulvae. Methods: Twelve postmenopausal diabetic women with vulvar lichen simplex chronicus were enrolled in this trial. Each patient was treated with pimecrolimus 1% cream which was applied twice daily in a thin layer to the vulvae for 3 months. Clinical examination and recording of patients' symptoms using a scoring system was performed by the same physician before, after 4 weeks and after 3 months of therapy. Results: All of the patients completed the study. A substantial decrease in pruritus after treatment was reported by the patients at the 4th week (2.17±0.72, p<0.01) and 3rd month of treatment (0.42±0.92, p<0.001) when compared with the baseline score (3.75±0.45). Follow‐up of the patients after 3 months of treatment showed that complete cure occurred in 10 patients (83.3%) and the pruritus was improved in two (16.7%) patients. Conclusions: Pimecrolimus 1% cream seems to be an effective and safe treatment modality for pruritus in postmenopausal women with vulvar lichen simplex chronicus.